Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells

Molecular and Cellular Biology

Volumn 35, Issue 7, 2015, Pages 1068-1080

  Nagaoka, Katsuya ^a,b   Hino, Shinjiro ^a   Sakamoto, Akihisa ^a   Anan, Kotaro ^a   Takase, Ryuta ^a   Umehara, Takashi ^c   Yokoyama, Shigeyuki ^c   Sasaki, Yutaka ^b   Nakao, Mitsuyoshi ^a,d  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HISTONE H3; LIPID; PROTEIN C JUN; RETINOBLASTOMA BINDING PROTEIN 2; HISTONE; HISTONE DEMETHYLASE; LYSINE; LYSINE (K)-SPECIFIC DEMETHYLASE 1B, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL STRESS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEMETHYLATION; DEPLETION; ENERGY BALANCE; EPIGENETICS; GENE LOCUS; GENE REPRESSION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID TRANSPORT; LIVER CELL; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DOWN REGULATION; GENETICS; HEPG2 CELL LINE; LIVER; METABOLISM; METHYLATION;

ANIMALS; DOWN-REGULATION; HEP G2 CELLS; HEPATOCYTES; HISTONE DEMETHYLASES; HISTONES; HUMANS; LIPID METABOLISM; LIPIDS; LIVER; LYSINE; MALE; METHYLATION; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-JUN;

EID: 84924853594     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01404-14     Document Type: Article

References (43)

1. Feil R, Fraga MF. 2012. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 13:97-109. http://dx.doi.org/10.1038/nrg3142.
2. Jimenez-Chillarón JC, Diaz R, Martinez D, Pentinat T, Ramon-Krauel M, Ribo S, Plosch T. 2012. The role of nutrition on epigenetic modifications and their implications on health. Biochimie 94:2242-2263. http://dx.doi.org/10.1016/j.biochi.2012.06.012.
3. Feinberg AP. 2007. Phenotypic plasticity and the epigenetics of human disease. Nature 447:433-440. http://dx.doi.org/10.1038/nature05919.
4. Gut P, Verdin E. 2013. The nexus of chromatin regulation and intermediary metabolism. Nature 502:489-498. http://dx.doi.org/10.1038/nature12752.
5. Kaelin WG, Jr, McKnight SL. 2013. Influence of metabolism on epigenetics and disease. Cell 153:56-69. http://dx.doi.org/10.1016/j.cell.2013.03.004.
6. Hino S, Nagaoka K, Nakao M. 2013. Metabolism-epigenome crosstalk in physiology and diseases. J Hum Genet 58:410-415. http://dx.doi.org/10.1038/jhg.2013.57.
7. Pedersen MT, Helin K. 2010. Histone demethylases in development and disease. Trends Cell Biol 20:662-671. http://dx.doi.org/10.1016/j.tcb.2010.08.011.
8. Karytinos A, Forneris F, Profumo A, Ciossani G, Battaglioli E, Binda C, Mattevi A. 2009. A novel mammalian flavin-dependent histone demethylase. J Biol Chem 284:17775-17782. http://dx.doi.org/10.1074/jbc. M109.003087.
9. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953. http://dx.doi.org/10.1016/j.cell.2004.12.012.
10. Lienhart WD, Gudipati V, Macheroux P. 2013. The human flavoproteome. Arch Biochem Biophys 535:150-162. http://dx.doi.org/10.1016/j.abb.2013.02.015.
11. Hino S, Sakamoto A, Nagaoka K, Anan K, Wang Y, Mimasu S, Umehara T, Yokoyama S, Kosai K, Nakao M. 2012. FAD-dependent lysinespecific demethylase-1 regulates cellular energy expenditure. Nat Commun 3:758. http://dx.doi.org/10.1038/ncomms1755.
12. Duteil D, Metzger E, Willmann D, Karagianni P, Friedrichs N, Greschik H, Gunther T, Buettner R, Talianidis I, Metzger D, Schule R. 2014. LSD1 promotes oxidative metabolism of white adipose tissue. Nat Commun 5:4093. http://dx.doi.org/10.1038/ncomms5093.
13. Yang Z, Jiang J, Stewart DM, Qi S, Yamane K, Li J, Zhang Y, Wong J. 2010. AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function. Cell Res 20:276-287. http://dx.doi.org/10.1038/cr.2010.12.
14. Fang R, Barbera AJ, Xu Y, Rutenberg M, Leonor T, Bi Q, Lan F, Mei P, Yuan GC, Lian C, Peng J, Cheng D, Sui G, Kaiser UB, Shi Y, Shi YG. 2010. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol Cell 39:222-233. http://dx.doi.org/10.1016/j.molcel.2010.07.008.
15. van Essen D, Zhu Y, Saccani S. 2010. A feed-forward circuit controlling inducible NF-kappaB target gene activation by promoter histone demethylation. Mol Cell 39:750-760. http://dx.doi.org/10.1016/j.molcel.2010.08.010.
16. Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J, Xu G, Li E, Chen T. 2009. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 461:415-418. http://dx.doi.org/10.1038/nature08315.
17. Murray RK, Granner DK, Mayes PA, Rodwell VW. 1999. Harper's biochemistry, 25th ed. Maruzen Co., Ltd., Tokyo, Japan.
18. Cusi K. 2012. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142:711-725.e716. http://dx.doi.org/10.1053/j.gastro.2012.02.003.
19. Leamy AK, Egnatchik RA, Young JD. 2013. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 52:165-174. http://dx.doi.org/10.1016/j.plipres.2012.10.004.
20. Sookoian S, Rosselli MS, Gemma C, Burgueno AL, Fernandez Gianotti T, Castano GO, Pirola CJ. 2010. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter. Hepatology 52:1992-2000. http://dx.doi.org/10.1002/hep.23927.
21. Pogribny IP, Tryndyak VP, Bagnyukova TV, Melnyk S, Montgomery B, Ross SA, Latendresse JR, Rusyn I, Beland FA. 2009. Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol 51:176-186. http://dx.doi.org/10.1016/j.jhep.2009.03.021.
22. Ahrens M, Ammerpohl O, von Schonfels W, Kolarova J, Bens S, Itzel T, Teufel A, Herrmann A, Brosch M, Hinrichsen H, Erhart W, Egberts J, Sipos B, Schreiber S, Hasler R, Stickel F, Becker T, Krawczak M, Rocken C, Siebert R, Schafmayer C, Hampe J. 2013. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab 18:296-302. http://dx.doi.org/10.1016/j.cmet.2013.07.004.
23. Fujita N, Watanabe S, Ichimura T, Tsuruzoe S, Shinkai Y, Tachibana M, Chiba T, Nakao M. 2003. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem 278:24132-24138. http://dx.doi.org/10.1074/jbc. M302283200.
24. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137. http://dx.doi.org/10.1186/gb-2008-9-9-r137.
25. Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. 2010. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6:78-95. http://dx.doi.org/10.1007/s11306-009-0178-y.
26. Saldanha AJ. 2004. Java Treeview-extensible visualization of microarray data. Bioinformatics 20:3246-3248. http://dx.doi.org/10.1093/bioinform atics/bth349.
27. Pan D, Mao C, Wang YX. 2013. Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation. PLoS One 8:e66294. http://dx.doi.org/10.1371/journal.pone.0066294.
28. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. 2003. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273. http://dx.doi.org/10.1038/ng1180.
29. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550. http://dx.doi.org/10.1073/pnas.0506580102.
30. Fang R, Chen F, Dong Z, Hu D, Barbera AJ, Clark EA, Fang J, Yang Y, Mei P, Rutenberg M, Li Z, Zhang Y, Xu Y, Yang H, Wang P, Simon MD, Zhou Q, Li J, Marynick MP, Li X, Lu H, Kaiser UB, Kingston RE, Xu Y, Shi YG. 2013. LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation. Mol Cell 49:558-570. http://dx.doi.org/10.1016/j.molcel.2012.11.019.
31. Calo E, Wysocka J. 2013. Modification of enhancer chromatin: what, how, and why? Mol Cell 49:825-837. http://dx.doi.org/10.1016/j.molcel.2013.01.038.
32. Zhou VW, Goren A, Bernstein BE. 2011. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 12:7-18. http://dx.doi.org/10.1038/nrg2905.
33. Seki E, Brenner DA, Karin M. 2012. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143:307-320. http://dx.doi.org/10.1053/j.gastro.2012.06.004.
34. Czaja MJ. 2010. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab 21:707-713. http://dx.doi.org/10.1016/j.tem.2010.08.010.
35. Kakisaka K, Cazanave SC, Fingas CD, Guicciardi ME, Bronk SF, Werneburg NW, Mott JL, Gores GJ. 2012. Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis. Am J Physiol Gastrointest Liver Physiol 302:G77-G84. http://dx.doi.org/10.1152/ajpgi.00301.2011.
36. Hasenfuss SC, Bakiri L, Thomsen MK, Williams EG, Auwerx J, Wagner EF. 2014. Regulation of steatohepatitis and PPARgamma signaling by distinct AP-1 dimers. Cell Metab 19:84-95. http://dx.doi.org/10.1016/j.cmet.2013.11.018.
37. Glatz JF, Luiken JJ, Bonen A. 2010. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 90:367-417. http://dx.doi.org/10.1152/physrev.00003.2009.
38. Hebbard L, George J. 2011. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 8:35-44. http://dx.doi.org/10.1038/nrgastro.2010.191.
39. Gupta J, Kumar S, Li J, Krishna Murthy Karuturi R, Tikoo K. 2012. Histone H3 lysine 4 monomethylation (H3K4me1) and H3 lysine 9 monomethylation (H3K9me1): distribution and their association in regulating gene expression under hyperglycaemic/hyperinsulinemic conditions in 3T3 cells. Biochimie 94:2656-2664. http://dx.doi.org/10.1016/j.biochi.2012.08.011.
40. Veazey KJ, Carnahan MN, Muller D, Miranda RC, Golding MC. 2013. Alcohol-induced epigenetic alterations to developmentally crucial genes regulating neural stemness and differentiation. Alcohol Clin Exp Res 37: 1111-1122. http://dx.doi.org/10.1111/acer.12080.
41. Fuest M, Willim K, MacNelly S, Fellner N, Resch GP, Blum HE, Hasselblatt P. 2012. The transcription factor c-Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survival. Hepatology 55:408-418. http://dx.doi.org/10.1002/hep.24699.
42. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39:311-318. http://dx.doi.org/10.1038/ng1966.
43. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129:823-837. http://dx.doi.org/10.1016/j.cell.2007.05.009.